Electroducer announces major medical advance in treatment of heart valve disease; raises €3 million to market its device in Europe and US – commencing in 2022
Hephaï files software patent for its digital education platform designed to improve patient inhaler use
CarThera’s SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors
Robocath successfully completes first robotic coronary angioplasties in Belgium
Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology
Chiesi and Hephaï join forces to develop AI educational tool to improve inhaler use
REGEnLIFE presents first results of pilot clinical trial evaluating photobiomodulation technology in the treatment of Alzheimer’s disease
• Within treated patient group, trends showed improved cognitive and executive functions, improved language comprehension and verbal memory, in comparison to placebo group
• REGEnLIFE’s technology shown to be safe and well-tolerated by patients
• Initial results open up new possibilities for development of brain-gut stimulation device for prevention and treatment of neurodegenerative diseases
Vygon Group takes part in UICC World Cancer Day 2021
